These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 10371572)

  • 1. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
    Phillips M; Gleeson K; Hughes JM; Greenberg J; Cataneo RN; Baker L; McVay WP
    Lancet; 1999 Jun; 353(9168):1930-3. PubMed ID: 10371572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of lung cancer with volatile markers in the breath.
    Phillips M; Cataneo RN; Cummin AR; Gagliardi AJ; Gleeson K; Greenberg J; Maxfield RA; Rom WN
    Chest; 2003 Jun; 123(6):2115-23. PubMed ID: 12796197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volatile biomarkers of pulmonary tuberculosis in the breath.
    Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
    Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
    PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of lung cancer using volatile biomarkers in breath.
    Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Greenberg J; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P
    Cancer Biomark; 2007; 3(2):95-109. PubMed ID: 17522431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
    Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
    Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile markers of breast cancer in the breath.
    Phillips M; Cataneo RN; Ditkoff BA; Fisher P; Greenberg J; Gunawardena R; Kwon CS; Rahbari-Oskoui F; Wong C
    Breast J; 2003; 9(3):184-91. PubMed ID: 12752626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breath testing as a method for detecting lung cancer.
    Taivans I; Bukovskis M; Strazda G; Jurka N
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of statistical methods using VOCs to identify patients with lung cancer.
    Ulanowska A; Kowalkowski T; Trawińska E; Buszewski B
    J Breath Res; 2011 Dec; 5(4):046008. PubMed ID: 22071773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
    Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
    Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breath markers of oxidative stress in patients with unstable angina.
    Phillips M; Cataneo RN; Greenberg J; Grodman R; Salazar M
    Heart Dis; 2003; 5(2):95-9. PubMed ID: 12713676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for the collection and assay of volatile organic compounds in breath.
    Phillips M
    Anal Biochem; 1997 May; 247(2):272-8. PubMed ID: 9177688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The screening of volatile markers for hepatocellular carcinoma.
    Qin T; Liu H; Song Q; Song G; Wang HZ; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2247-53. PubMed ID: 20826831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.